Sagimet Biosciences
SGMT
$3.96
Share price
-4.35%
Change (1 day)
N/A
Change (1 year)
Categories
Sagimet Biosciences (SGMT) - Cash on Hand
Cash on Hand as of March 2024 : $0.19 B
According to Sagimet Biosciences's latest financial reports the company has $0.19 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sagimet Biosciences - Cash on Hand chart (from 2021 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $32.34 M | -42.99% |
| 2021-12-31 | $56.73 M | -17.42% |
| 2020-12-31 | $68.7 M | 572.76% |
| 2019-12-31 | $10.21 M |